Maccura BiotechnologyLtd Balance Sheet Health
Financial Health criteria checks 6/6
Maccura BiotechnologyLtd has a total shareholder equity of CN¥6.6B and total debt of CN¥744.5M, which brings its debt-to-equity ratio to 11.2%. Its total assets and total liabilities are CN¥8.2B and CN¥1.6B respectively. Maccura BiotechnologyLtd's EBIT is CN¥288.7M making its interest coverage ratio 18.8. It has cash and short-term investments of CN¥950.0M.
Key information
11.2%
Debt to equity ratio
CN¥744.49m
Debt
| Interest coverage ratio | 18.8x |
| Cash | CN¥950.03m |
| Equity | CN¥6.62b |
| Total liabilities | CN¥1.59b |
| Total assets | CN¥8.21b |
Recent financial health updates
Recent updates
Even With A 38% Surge, Cautious Investors Are Not Rewarding Maccura Biotechnology Co.Ltd's (SZSE:300463) Performance Completely
Oct 08
Is Maccura BiotechnologyLtd (SZSE:300463) Using Too Much Debt?
Aug 01Many Still Looking Away From Maccura Biotechnology Co.Ltd (SZSE:300463)
May 28Some Investors May Be Willing To Look Past Maccura BiotechnologyLtd's (SZSE:300463) Soft Earnings
May 01Financial Position Analysis
Short Term Liabilities: 300463's short term assets (CN¥3.9B) exceed its short term liabilities (CN¥1.2B).
Long Term Liabilities: 300463's short term assets (CN¥3.9B) exceed its long term liabilities (CN¥348.7M).
Debt to Equity History and Analysis
Debt Level: 300463 has more cash than its total debt.
Reducing Debt: 300463's debt to equity ratio has reduced from 43.7% to 11.2% over the past 5 years.
Debt Coverage: 300463's debt is well covered by operating cash flow (104.4%).
Interest Coverage: 300463's interest payments on its debt are well covered by EBIT (18.8x coverage).